| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P50 | author | Rajendra Prasad | Q89926093 |
| P2093 | author name string | Neeraj Chauhan | |
| Virander Singh Chauhan | |||
| Andrew M Lynn | |||
| Jyotsna Sharma | |||
| Indresh Kumar Maurya | |||
| Manpreet Kaur Rawal | |||
| Balaguru Ravikumar | |||
| Sobhan Sen | |||
| Chaitanya Kumar Thota | |||
| Sachin Dev Verma | |||
| P2860 | cites work | Molecular aspects of fluconazole resistance development in Candida albicans | Q43899356 |
| Antimicrobial action of prototypic amphipathic cationic decapeptides and their branched dimers | Q46016562 | ||
| Characterization of Cdr1p, a major multidrug efflux protein of Candida albicans: purified protein is amenable to intrinsic fluorescence analysis. | Q46942247 | ||
| Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor. | Q51795077 | ||
| Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides | Q56390180 | ||
| Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candidaalbicans strains | Q61658940 | ||
| Synergy, antagonism, and what the chequerboard puts between them | Q73521098 | ||
| Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides | Q77296547 | ||
| PRALINETM: a strategy for improved multiple alignment of transmembrane proteins | Q80442814 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| Transmembrane helix dimerization: beyond the search for sequence motifs | Q26865109 | ||
| Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method | Q29547550 | ||
| The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport | Q33560121 | ||
| Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods | Q33695704 | ||
| Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. | Q33721804 | ||
| Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans | Q33826488 | ||
| Comparative lipidomics of azole sensitive and resistant clinical isolates of Candida albicans reveals unexpected diversity in molecular lipid imprints | Q33894971 | ||
| Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters | Q33983544 | ||
| Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor | Q34334444 | ||
| Analysis of protein interactions using fluorescence technologies | Q35568893 | ||
| Functional characterization of Candida albicans ABC transporter Cdr1p. | Q35697281 | ||
| Serum differentially alters the antifungal properties of echinocandin drugs | Q35840860 | ||
| Homodimerization of amyloid precursor protein at the plasma membrane: a homoFRET study by time-resolved fluorescence anisotropy imaging | Q36207429 | ||
| Changing patterns and trends in systemic fungal infections | Q36239992 | ||
| Efflux-mediated antifungal drug resistance. | Q37156645 | ||
| Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals | Q37274696 | ||
| Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p | Q37337658 | ||
| Yeast ATP-binding cassette transporters conferring multidrug resistance | Q38019037 | ||
| Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis | Q38350658 | ||
| The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans | Q38626885 | ||
| Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. | Q39559578 | ||
| Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters | Q39746465 | ||
| Transmembrane inhibitors of P-glycoprotein, an ABC transporter | Q40417473 | ||
| Drug efflux by a small multidrug resistance protein is inhibited by a transmembrane peptide | Q41994971 | ||
| Rationale-based, de novo design of dehydrophenylalanine-containing antibiotic peptides and systematic modification in sequence for enhanced potency | Q42067261 | ||
| A key structural domain of the Candida albicans Mdr1 protein. | Q43551296 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida albicans | Q310443 |
| protein design | Q410814 | ||
| transmembrane protein | Q424204 | ||
| multiple drug resistance | Q643839 | ||
| P1104 | number of pages | 13 | |
| P304 | page(s) | 16775-16787 | |
| P577 | publication date | 2013-04-16 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans | |
| P478 | volume | 288 |
| Q36645559 | A New Endogenous Overexpression System of Multidrug Transporters of Candida albicans Suitable for Structural and Functional Studies. |
| Q57159898 | All about Candida Drug Resistance CDRs: Past, Present and Future |
| Q47260402 | CYSTM, a Novel Non-secreted Cysteine-rich Peptide Family, Involved in Environmental Stresses in Arabidopsis thaliana |
| Q38214603 | Challenges and future prospects of antibiotic therapy: from peptides to phages utilization. |
| Q42729942 | Efflux by small multidrug resistance proteins is inhibited by membrane-interactive helix-stapled peptides |
| Q93349137 | Fluorescent peptides for imaging of fungal cells |
| Q28547078 | Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance |
| Q38222087 | Interplay between Candida albicans and the antimicrobial peptide armory. |
| Q38131288 | Lipids of Candida albicans and their role in multidrug resistance |
| Q90460091 | Make azoles active again: chalcones as potent reversal agents of transporters-mediated resistance in Candida albicans |
| Q42710187 | Mechanism of action of novel synthetic dodecapeptides against Candida albicans |
| Q48041333 | Modulators of the Efflux Pump Cdr1p of Candida albicans: Mechanisms of Action and Chemical Features. |
| Q91853838 | Multidrug transporters of Candida species in clinical azole resistance |
| Q38833324 | Natural and synthetic peptides with antifungal activity |
| Q94446819 | Octyl gallate reduce ABC multidrug transporter CaCdr1p expression and lead to its mislocalization in azole-resistant clinical isolates of Candida albicans |
| Q100480780 | Peptide-Based Approach to Inhibition of the Multidrug Resistance Efflux Pump AcrB |
| Q57120472 | Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA) |
| Q39160527 | Resistance to antifungal therapies |
| Q53794478 | Robust Chemical Synthesis of Membrane Proteins through a General Method of Removable Backbone Modification. |
| Q38837348 | Targeting efflux pumps to overcome antifungal drug resistance |
| Q26786747 | The ABCs of Candida albicans Multidrug Transporter Cdr1 |
| Q47681753 | The role of EscD in supporting EscC polymerization in the type III secretion system of enteropathogenic Escherichia coli |
| Q38942351 | Therapeutic design of peptide modulators of protein-protein interactions in membranes |
| Q86279247 | Trifluoroethanol-containing RP-HPLC mobile phases for the separation of transmembrane peptides human glycophorin-A, integrin alpha-1, and p24: analysis and prevention of potential side reactions due to formic acid |
| Q92640643 | Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux |
Search more.